Amyotrophic Lateral Sclerosis Treatment and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Amyotrophic Lateral Sclerosis Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Amyotrophic Lateral Sclerosis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Amyotrophic Lateral Sclerosis Treatment Overall Market Size
2.1 Global Amyotrophic Lateral Sclerosis Treatment Market Size: 2022 VS 2029
2.2 Global Amyotrophic Lateral Sclerosis Treatment Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Amyotrophic Lateral Sclerosis Treatment Players in Global Market
3.2 Top Global Amyotrophic Lateral Sclerosis Treatment Companies Ranked by Revenue
3.3 Global Amyotrophic Lateral Sclerosis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Amyotrophic Lateral Sclerosis Treatment Companies in Global Market, by Revenue in 2022
3.5 Global Companies Amyotrophic Lateral Sclerosis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Treatment Players in Global Market
3.6.1 List of Global Tier 1 Amyotrophic Lateral Sclerosis Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Amyotrophic Lateral Sclerosis Treatment Market Size Markets, 2022 & 2029
4.1.2 Medication
4.1.3 Physical Therapy
4.1.4 Speech Therapy
4.1.5 Others
4.2 By Type - Global Amyotrophic Lateral Sclerosis Treatment Revenue & Forecasts
4.2.1 By Type - Global Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2023
4.2.2 By Type - Global Amyotrophic Lateral Sclerosis Treatment Revenue, 2024-2029
4.2.3 By Type - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Amyotrophic Lateral Sclerosis Treatment Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Specialty Centers
5.1.4 Research Centers
5.1.5 Others
5.2 By Application - Global Amyotrophic Lateral Sclerosis Treatment Revenue & Forecasts
5.2.1 By Application - Global Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2023
5.2.2 By Application - Global Amyotrophic Lateral Sclerosis Treatment Revenue, 2024-2029
5.2.3 By Application - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Amyotrophic Lateral Sclerosis Treatment Market Size, 2022 & 2029
6.2 By Region - Global Amyotrophic Lateral Sclerosis Treatment Revenue & Forecasts
6.2.1 By Region - Global Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2023
6.2.2 By Region - Global Amyotrophic Lateral Sclerosis Treatment Revenue, 2024-2029
6.2.3 By Region - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2029
6.3.2 US Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.3.3 Canada Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.3.4 Mexico Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2029
6.4.2 Germany Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.4.3 France Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.4.4 U.K. Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.4.5 Italy Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.4.6 Russia Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.4.7 Nordic Countries Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.4.8 Benelux Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2029
6.5.2 China Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.5.3 Japan Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.5.4 South Korea Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.5.5 Southeast Asia Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.5.6 India Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2029
6.6.2 Brazil Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.6.3 Argentina Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2029
6.7.2 Turkey Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.7.3 Israel Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.7.4 Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
6.7.5 UAE Amyotrophic Lateral Sclerosis Treatment Market Size, 2018-2029
7 Amyotrophic Lateral Sclerosis Treatment Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.1.4 Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.2.4 Roche Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Biogen
7.3.1 Biogen Company Summary
7.3.2 Biogen Business Overview
7.3.3 Biogen Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.3.4 Biogen Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.3.5 Biogen Key News & Latest Developments
7.4 Mitsubishi Tanabe Pharma
7.4.1 Mitsubishi Tanabe Pharma Company Summary
7.4.2 Mitsubishi Tanabe Pharma Business Overview
7.4.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.4.4 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.4.5 Mitsubishi Tanabe Pharma Key News & Latest Developments
7.5 GNT Pharma
7.5.1 GNT Pharma Company Summary
7.5.2 GNT Pharma Business Overview
7.5.3 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.5.4 GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.5.5 GNT Pharma Key News & Latest Developments
7.6 Synthetic Biologics
7.6.1 Synthetic Biologics Company Summary
7.6.2 Synthetic Biologics Business Overview
7.6.3 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.6.4 Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.6.5 Synthetic Biologics Key News & Latest Developments
7.7 Amkor Pharma
7.7.1 Amkor Pharma Company Summary
7.7.2 Amkor Pharma Business Overview
7.7.3 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.7.4 Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.7.5 Amkor Pharma Key News & Latest Developments
7.8 ViroMed
7.8.1 ViroMed Company Summary
7.8.2 ViroMed Business Overview
7.8.3 ViroMed Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.8.4 ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.8.5 ViroMed Key News & Latest Developments
7.9 Brainstorm Therapeutics
7.9.1 Brainstorm Therapeutics Company Summary
7.9.2 Brainstorm Therapeutics Business Overview
7.9.3 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.9.4 Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.9.5 Brainstorm Therapeutics Key News & Latest Developments
7.10 Bausch Health
7.10.1 Bausch Health Company Summary
7.10.2 Bausch Health Business Overview
7.10.3 Bausch Health Amyotrophic Lateral Sclerosis Treatment Major Product Offerings
7.10.4 Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue in Global Market (2018-2023)
7.10.5 Bausch Health Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Amyotrophic Lateral Sclerosis Treatment Market Opportunities & Trends in Global Market
Table 2. Amyotrophic Lateral Sclerosis Treatment Market Drivers in Global Market
Table 3. Amyotrophic Lateral Sclerosis Treatment Market Restraints in Global Market
Table 4. Key Players of Amyotrophic Lateral Sclerosis Treatment in Global Market
Table 5. Top Amyotrophic Lateral Sclerosis Treatment Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Amyotrophic Lateral Sclerosis Treatment Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Amyotrophic Lateral Sclerosis Treatment Revenue Share by Companies, 2018-2023
Table 8. Global Companies Amyotrophic Lateral Sclerosis Treatment Product Type
Table 9. List of Global Tier 1 Amyotrophic Lateral Sclerosis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Amyotrophic Lateral Sclerosis Treatment Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Amyotrophic Lateral Sclerosis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Amyotrophic Lateral Sclerosis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Amyotrophic Lateral Sclerosis Treatment Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Amyotrophic Lateral Sclerosis Treatment Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2024-2029
Table 30. Sanofi Company Summary
Table 31. Sanofi Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 32. Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 36. Roche Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Biogen Company Summary
Table 39. Biogen Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 40. Biogen Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 41. Biogen Key News & Latest Developments
Table 42. Mitsubishi Tanabe Pharma Company Summary
Table 43. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 44. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 45. Mitsubishi Tanabe Pharma Key News & Latest Developments
Table 46. GNT Pharma Company Summary
Table 47. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 48. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 49. GNT Pharma Key News & Latest Developments
Table 50. Synthetic Biologics Company Summary
Table 51. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 52. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 53. Synthetic Biologics Key News & Latest Developments
Table 54. Amkor Pharma Company Summary
Table 55. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 56. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 57. Amkor Pharma Key News & Latest Developments
Table 58. ViroMed Company Summary
Table 59. ViroMed Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 60. ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 61. ViroMed Key News & Latest Developments
Table 62. Brainstorm Therapeutics Company Summary
Table 63. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 64. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 65. Brainstorm Therapeutics Key News & Latest Developments
Table 66. Bausch Health Company Summary
Table 67. Bausch Health Amyotrophic Lateral Sclerosis Treatment Product Offerings
Table 68. Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue (US$, Mn) & (2018-2023)
Table 69. Bausch Health Key News & Latest Developments
List of Figures
Figure 1. Amyotrophic Lateral Sclerosis Treatment Segment by Type in 2022
Figure 2. Amyotrophic Lateral Sclerosis Treatment Segment by Application in 2022
Figure 3. Global Amyotrophic Lateral Sclerosis Treatment Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Amyotrophic Lateral Sclerosis Treatment Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Amyotrophic Lateral Sclerosis Treatment Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Treatment Revenue in 2022
Figure 8. By Type - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 9. By Application - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 10. By Type - Global Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 12. By Application - Global Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 14. By Region - Global Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 15. By Country - North America Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 16. US Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 20. Germany Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 21. France Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 28. China Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 32. India Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 34. Brazil Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Revenue Market Share, 2018-2029
Figure 37. Turkey Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Amyotrophic Lateral Sclerosis Treatment Revenue, (US$, Mn), 2018-2029
Figure 41. Sanofi Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Biogen Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. GNT Pharma Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Synthetic Biologics Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Amkor Pharma Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. ViroMed Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Brainstorm Therapeutics Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bausch Health Amyotrophic Lateral Sclerosis Treatment Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
